Online edition of India's National Newspaper
Monday, Sep 12, 2005
Google

Tamil Nadu
News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Classifieds | Employment |

Tamil Nadu - Chennai Printer Friendly Page   Send this Article to a Friend

Symposium on trends in cardiology

Staff Reporter

Cherian speaks on non-invasive treatment and diagnostic modalities of the disease

CHENNAI: A continuing medical education programme on "Newer trend in cardiology" was held at Kilpauk Medical College.

K.M. Cherian, chairman of Frontier Lifeline, spoke on the role of non-invasive treatment and diagnostic modality in managing cardiovascular diseases.

The symposium, also attended by cardiologists from private hospitals, focused on cardiac patients who were beyond the ambit of available and hybrid modalities that could be practiced to rectify the defects.

Chest pain

Dr. Cherian said: "The main idea [behind the symposium] is to enunciate the competence of enhanced external counterpulsation [EECP] treatment that increases the role of the cardiologist to treat patients with chest pain and poor exercise tolerance who have reached maximal medication and amendable for conventional interventional procedures. We cardiologists are adapting ourselves to a range of newer trends in cardiology to treat patients efficiently and to convene with international standards in the field of cardiology."

Blood supply

The EECP creates a natural mechanism to boost blood supply through adjustable pneumatic cuffs that are wrapped around the lower parts of the body.

The procedure is done several times, usually in 35 one-hour out patient sessions, six times a week for seven weeks.

The treatment works in areas of blood circulation where bypass surgery and angioplasty is not possible.

When blocked arteries prevent blood supply to the heart, the procedure helps to maintain supply through minute blood vessels or the dormant collaterals to the portion of heart starved of blood.

Standard procedure

Cardiothoracic surgeons and invasive cardiologists can use the treatment as adjuvant to standard interventional procedure.

The U.S. Food and Drug Administration, has approved the treatment for chronic angina and heart failure.

Printer friendly page  
Send this article to Friends by E-Mail



Tamil Nadu

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Classifieds | Employment | Updates: Breaking News |


News Update


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu